Secondary brain lesions resulting from cerebral metabolic and hemodynamic r
eactions can be prevented by neurocritical care management. It must be init
iated as soon as possible, ideally in a prehospital setting. Tracheal intub
ation, controlled ventilation and hemodynamic stabilization are the prerequ
isites. Beside intracranial and cerebral perfusion pressure, monitoring mus
t evaluate the coupling between cerebral metabolic demand and blood flow. J
ugular bulb oximetry is the most reliable approach to global cerebral coupl
ing. Transcranial Doppler evaluates cerebral blood flow indirectly and noni
nvasively. Technological developments have led to local metabolic evaluatio
n that does not yet have any clinical relevance. Therapeutic developments a
re more a new approach to the use of old drugs. Controlled hyperventilation
, mannitol and, more recently, hypertonic saline solutions, used for restor
ing cerebral metabolic coupling, are the foundations of treatment. Thiopent
al, revisited as a vasoconstrictive agent, the "Lund" vasoconstrictive appr
oach with anti-hypertensive drugs and cerebral vasoconstrictors, must be fu
rther evaluated in children, as must therapeutic hypothermia. Finally, what
we probably need for the immediate future is a noninvasive and easily repr
oducible method of monitoring cerebral metabolic coupling that will allow p
recise therapeutic adaptation of multimodal therapy to the individual needs
of the child.